# ANeuroTech jobs and careers

> 0 open roles at ANeuroTech as of October 24, 2026. Source: https://www.thejobsmap.com/company/aneurotech

ANEUROTECH is developing its late stage Phase III drug ANT01 in Partial Responsive Depression (PRD). ANT01 is an once daily, orally-administered small molecule to attack Subjective Cognitive Decline and Potentiate Initial Antidepressant Therapies.

## Key facts

| | |
|---|---|
| Open roles | 0 |
| Headquarters | Belgium |
| Employees | 1 to 10 |
| Website | https://aneurotech.com |

## Leadership

- Erik Buntinx, Founding Executive Chairman & Inventor

## Common questions

### Is ANeuroTech hiring right now?

ANeuroTech has no open roles listed as of October 24, 2026. Roles appear here as soon as they are posted on ANeuroTech's careers site.

### Where is ANeuroTech headquartered?

ANeuroTech is headquartered in Belgium.

### Who leads ANeuroTech?

Erik Buntinx, Founding Executive Chairman & Inventor, is at the top of ANeuroTech's org chart.

### How do I apply for a job at ANeuroTech?

Pick a role on ANeuroTech's TheJobsMap page and select Apply. Every listing links to the original posting on ANeuroTech's own careers site, so you apply directly with the employer.